GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Karolinska Development AB (STU:2I9) » Definitions » Cyclically Adjusted PB Ratio

Karolinska Development AB (STU:2I9) Cyclically Adjusted PB Ratio : 0.20 (As of Jun. 06, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Karolinska Development AB Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Karolinska Development AB's current share price is €0.1176. Karolinska Development AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.58. Karolinska Development AB's Cyclically Adjusted PB Ratio for today is 0.20.

The historical rank and industry rank for Karolinska Development AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:2I9' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.09   Med: 0.16   Max: 0.46
Current: 0.2

During the past years, Karolinska Development AB's highest Cyclically Adjusted PB Ratio was 0.46. The lowest was 0.09. And the median was 0.16.

STU:2I9's Cyclically Adjusted PB Ratio is ranked better than
81.69% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs STU:2I9: 0.20

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Karolinska Development AB's adjusted book value per share data for the three months ended in Mar. 2024 was €0.408. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.58 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Karolinska Development AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Karolinska Development AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karolinska Development AB Cyclically Adjusted PB Ratio Chart

Karolinska Development AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.10 0.33 0.14 0.20

Karolinska Development AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.16 0.17 0.20 0.20

Competitive Comparison of Karolinska Development AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Karolinska Development AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Karolinska Development AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Karolinska Development AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Karolinska Development AB's Cyclically Adjusted PB Ratio falls into.



Karolinska Development AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Karolinska Development AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.1176/0.58
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Karolinska Development AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Karolinska Development AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.408/132.2054*132.2054
=0.408

Current CPI (Mar. 2024) = 132.2054.

Karolinska Development AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.534 100.432 4.652
201409 2.941 100.161 3.882
201412 2.226 100.225 2.936
201503 2.552 99.950 3.376
201506 0.713 99.995 0.943
201509 0.655 100.228 0.864
201512 0.446 100.276 0.588
201603 0.266 100.751 0.349
201606 0.142 101.019 0.186
201609 0.104 101.138 0.136
201612 0.051 102.022 0.066
201703 0.124 102.022 0.161
201706 0.066 102.752 0.085
201709 0.384 103.279 0.492
201712 0.371 103.793 0.473
201803 0.335 103.962 0.426
201806 0.372 104.875 0.469
201809 0.375 105.679 0.469
201812 0.398 105.912 0.497
201903 0.365 105.886 0.456
201906 0.370 106.742 0.458
201909 0.349 107.214 0.430
201912 0.485 107.766 0.595
202003 0.409 106.563 0.507
202006 0.425 107.498 0.523
202009 0.346 107.635 0.425
202012 0.397 108.296 0.485
202103 0.385 108.360 0.470
202106 0.495 108.928 0.601
202109 0.492 110.338 0.590
202112 0.477 112.486 0.561
202203 0.457 114.825 0.526
202206 0.447 118.384 0.499
202209 0.422 122.296 0.456
202212 0.418 126.365 0.437
202303 0.401 127.042 0.417
202306 0.393 129.407 0.402
202309 0.391 130.224 0.397
202312 0.413 131.912 0.414
202403 0.408 132.205 0.408

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Karolinska Development AB  (STU:2I9) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Karolinska Development AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Karolinska Development AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Karolinska Development AB (STU:2I9) Business Description

Traded in Other Exchanges
Address
TomtebodavAgen 23 A, Solna, SWE, SE-171 65
Karolinska Development AB is a life science investment company. It is focused on identifying breakthrough medical innovations in the Nordic region. It selects commercially attractive medical innovations, develops innovations to the stage where the return on investment can be achieved and commercializes the innovations through the sale of companies or out-licensing of products. The company focused on profiles namely Aprea Therapeutics; Modus Therapeutics; BioArctic; Umecrine Cognition; and OssDsign.

Karolinska Development AB (STU:2I9) Headlines

No Headlines